Tag Archives: Chris Graf

Good Publication Practice, or GPP, is often the first port-of-call for companies publishing in the biomedical sector. But consider this. The first ideas for GPP were formed a decade ago, and now the time is right for GPP2: the new, revised Good Publication Practice. Why now? Pharma publication practice is a hot potato. Purported cases of publication-related [...]